文献速递冠心病瓣膜病与结构性心脏病

环状RNA CircMAP3K5通过吸附miR-22-3p促进TET2介导的平滑肌细胞分化与内膜增生消退

Circular RNA CircMAP3K5 Acts as a MicroRNA-22-3p Sponge to Promote Resolution of Intimal Hyperplasia Via TET2-Mediated Smooth Muscle Cell Differentiation.
PubMed 文献 · Circulation · 2020-11-19

该研究探讨环状RNA circMAP3K5是否作为miR-22-3p海绵调控血管内膜增生。在人和小鼠血管平滑肌细胞及股动脉导丝损伤模型中,circMAP3K5下调与损伤及疾病相关,过表达可抑制平滑肌细胞增殖并减少新生内膜形成,机制涉及吸附miR-22-3p进而抑制TET2表达。

要点

  • circMAP3K5在PDGF-BB处理的人冠状动脉平滑肌细胞及损伤血管中表达下调。
  • 过表达circMAP3K5抑制平滑肌细胞增殖并减少小鼠新生内膜形成。
  • circMAP3K5通过吸附miR-22-3p调控TET2介导的平滑肌细胞分化。

核心结论

  • circMAP3K5是TET2介导的血管平滑肌细胞分化的重要调控因子。
  • 靶向circMAP3K5/miR-22-3p/TET2轴可能为再狭窄和动脉粥样硬化等内膜增生性疾病提供治疗策略。

研究设计与样本

  • 研究比较了有无血小板衍生生长因子处理的人冠状动脉平滑肌细胞的全基因组RNA测序环状RNA谱。
  • 在扩张型心肌病或冠心病患者尸检冠状动脉中评估circMAP3K5表达,并在小鼠股动脉导丝损伤模型中用AAV9介导circMap3k5转染。
  • 使用平滑肌细胞特异性Tet2敲除小鼠和全身miR-22-3p敲除小鼠 delineate 机制。

主要发现

  • 血小板衍生生长因子-BB处理显著降低人冠状动脉平滑肌细胞中circMAP3K5表达。
  • 导丝损伤小鼠股动脉及冠心病患者病变动脉中circMAP3K5表达下调。
  • 慢病毒介导的circMAP3K5过表达抑制人冠状动脉平滑肌细胞增殖。
  • AAV9介导的circMap3k5转染特异性抑制损伤小鼠动脉平滑肌细胞增殖,减少新生内膜形成。
  • 荧光素酶报告基因和RNA pull-down显示circMAP3K5吸附miR-22-3p,进而抑制TET2表达;miR-22-3p缺失重现circMap3k5的抗增殖效应,而平滑肌细胞特异性Tet2敲除消除该效应。

临床怎么用

  • circMAP3K5/miR-22-3p/TET2轴可能作为干预血管内膜增生的潜在靶点。
  • circMAP3K5表达下调与血管损伤及冠心病相关,或可作为疾病标志物探索。

局限性

  • 研究主要基于动物模型和体外细胞实验,人体内治疗的有效性和安全性尚未验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aberrant expression of circular RNA contributes to human diseases. Circular RNAs regulate gene expression by sequestering specific microRNAs. In this study, we investigated whether circMAP3K5 (circular mitogen-activated protein kinase 5) could act as a competing endogenous microRNA-22-3p (miR-22-3p) sponge and regulate neointimal hyperplasia. METHODS: Circular RNA profiling from genome-wide RNA sequencing data was compared between human coronary artery smooth muscle cells (SMCs) treated with or without platelet-derived growth factor. Expression levels of circMAP3K5 were assessed in human coronary arteries from autopsies on patients with dilated cardiomyopathy or coronary heart disease. The role of circMAP3K5 in intimal hyperplasia was further investigated in mice with adeno-associated virus 9-mediated circMAP3K5 transfection. SMC-specific Tet2 (ten-eleven translocation-2) knockout mice and global miR-22-3p knockout mice were used to delineate the mechanism by which circMAP3K5 attenuated neointimal hyperplasia using the femoral arterial wire injury model. RESULTS: RNA sequencing demonstrated that treatment with platelet-derived growth factor-BB significantly reduced expression of circMAP3K5 in human coronary artery SMCs. Wire-injured mouse femoral arteries and diseased arteries from patients with coronary heart disease (where platelet-derived growth factor-BB is increased) confirmed in vivo downregulation of circMAP3K5 associated with injury and disease. Lentivirus-mediated overexpression of circMAP3K5 inhibited the proliferation of human coronary artery SMCs. In vivo adeno-associated virus 9-mediated transfection of circMap3k5 (mouse circular Map3k5) specifically inhibited SMC proliferation in the wire-injured mouse arteries, resulting in reduced neointima formation. Using a luciferase reporter assay and RNA pull-down, circMAP3K5 (human circular MAP3K5) was found to sequester miR-22-3p, which, in turn, inhibited the expression of TET2. Both in vitro and in vivo results demonstrate that the loss of miR-22-3p recapitulated the antiproliferative effect of circMap3k5 on vascular SMCs. In SMC-specific Tet2 knockout mice, loss of Tet2 abolished the circMap3k5-mediated antiproliferative effect on vascular SMCs. CONCLUSIONS: We identify circMAP3K5 as a master regulator of TET2-mediated vascular SMC differentiation. Targeting the circMAP3K5/miR-22-3p/TET2 axis may provide a potential therapeutic strategy for diseases associated with intimal hyperplasia, including restenosis and atherosclerosis.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Zeng Z, Xia L, Fan S, et al. Circular RNA CircMAP3K5 Acts as a MicroRNA-22-3p Sponge to Promote Resolution of Intimal Hyperplasia Via TET2-Mediated Smooth Muscle Cell Differentiation. Circulation. 2020. PMID: 33207953. doi:10.1161/CIRCULATIONAHA.120.049715

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。